Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ANAQUANT provides advanced mass spectrometry-based bioanalytical services specializing in targeted protein quantification for pharmaceutical and biotech companies. Their expertise includes host cell protein identification/quantification, biomarker discovery/validation, biologics characterization, therapeutic peptide analysis, and vaccine-related analytics. They offer custom assay development using proprietary technologies such as READYBEADS to improve robustness in proteomic analyses. Their work supports preclinical research through to product validation but does not include direct clinical trial programs or marketed drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ANAQUANT.